4-Bromo-2,5-dimethoxyamphetamine

DB01484

small molecule experimental illicit

Deskripsi

Struktur Molekul 2D

Berat 274.154
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1319 Data
Valsartan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Valsartan.
Ramipril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Ramipril.
Remikiren 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Remikiren.
Torasemide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Torasemide.
Isradipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Isradipine.
Olmesartan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Olmesartan.
Chlorthalidone 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Chlorthalidone.
Nitroprusside 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Nitroprusside.
Diltiazem 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Diltiazem.
Minoxidil 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Minoxidil.
Treprostinil 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Treprostinil.
Amlodipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Amlodipine.
Nimodipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Nimodipine.
Nisoldipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Nisoldipine.
Bendroflumethiazide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Bendroflumethiazide.
Fosinopril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Fosinopril.
Trandolapril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Trandolapril.
Metolazone 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Metolazone.
Lercanidipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Lercanidipine.
Benazepril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Benazepril.
Bosentan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Bosentan.
Enalapril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Enalapril.
Cyclothiazide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Cyclothiazide.
Candoxatril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Candoxatril.
Mecamylamine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Mecamylamine.
Losartan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Losartan.
Moexipril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Moexipril.
Eplerenone 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Eplerenone.
Lisinopril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Lisinopril.
Nitroglycerin 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Nitroglycerin.
Hydroflumethiazide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Hydroflumethiazide.
Cryptenamine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Cryptenamine.
Perindopril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Perindopril.
Candesartan cilexetil 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Candesartan cilexetil.
Fenoldopam 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Fenoldopam.
Indapamide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Indapamide.
Tadalafil 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Tadalafil.
Eprosartan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Eprosartan.
Chlorothiazide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Chlorothiazide.
Quinapril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Quinapril.
Telmisartan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Telmisartan.
Methyldopa 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Methyldopa.
Hydrochlorothiazide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Hydrochlorothiazide.
Trichlormethiazide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Trichlormethiazide.
Irbesartan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Irbesartan.
Nitrendipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Nitrendipine.
Deserpidine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Deserpidine.
Pentolinium 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Pentolinium.
Trimethaphan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Trimethaphan.
Diazoxide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Diazoxide.
Captopril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Captopril.
Epoprostenol 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Epoprostenol.
Bepridil 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Bepridil.
Hydralazine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Hydralazine.
Polythiazide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Polythiazide.
Cilazapril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Cilazapril.
Saprisartan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Saprisartan.
Spirapril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Spirapril.
Mibefradil 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Mibefradil.
Tienilic acid 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Tienilic acid.
Debrisoquine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Debrisoquine.
Sitaxentan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Sitaxentan.
Ambrisentan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Ambrisentan.
Diethylnorspermine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Diethylnorspermine.
Nilvadipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Nilvadipine.
Pinacidil 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Pinacidil.
Temocapril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Temocapril.
Riociguat 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Riociguat.
Macitentan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Macitentan.
Aliskiren 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Aliskiren.
Nicorandil 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Nicorandil.
Efonidipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Efonidipine.
Lacidipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Lacidipine.
Manidipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Manidipine.
Rauwolfia serpentina root 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Rauwolfia serpentina root.
Enalaprilat 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Enalaprilat.
Selexipag 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Selexipag.
Angiotensin 1-7 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Angiotensin 1-7.
Imidapril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Imidapril.
BQ-123 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of BQ-123.
Cicletanine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Cicletanine.
Dihydralazine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Dihydralazine.
Zofenopril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Zofenopril.
Guanoxan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Guanoxan.
Delapril 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Delapril.
Vincamine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Vincamine.
Linsidomine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Linsidomine.
Guanoxabenz 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Guanoxabenz.
Tolonidine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Tolonidine.
Endralazine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Endralazine.
Cadralazine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Cadralazine.
Cyclopenthiazide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Cyclopenthiazide.
Bietaserpine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Bietaserpine.
Guanazodine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Guanazodine.
Methoserpidine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Methoserpidine.
Guanoclor 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Guanoclor.
Muzolimine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Muzolimine.
Xipamide 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Xipamide.
Candesartan 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Candesartan.
Dexniguldipine 4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Dexniguldipine.

Target Protein

5-hydroxytryptamine receptor 1D HTR1D
5-hydroxytryptamine receptor 2A HTR2A
5-hydroxytryptamine receptor 1A HTR1A

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul